 She found that the bacteria then stimulate the formation of granulomas that provide them a safe harbour, in contrast to the normal role of granulomas in protecting the host from the bacteria.Later the infected macrophages in the granulomas die, and this accelerates bacterial growth and promotes the development of the disease.These findings led to host-targeting therapies that show promise in tuberculosis patients.